Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Redx Pharma Plc RNS Release

Notice of Annual General Meeting

RNS Number : 9767B
Redx Pharma plc
07 April 2017
 

7 April 2017

AIM: REDX

REDX PHARMA PLC

("Redx" or "the Company")

 

Notice of Annual General Meeting

 

Redx Pharma, the research and development company focused on cancer, immunology and infection, announces that its Annual General Meeting will be held at 9.30am on 20 April 2017 at Redx Pharma Plc, Mereside, Alderley Park, Macclesfield SK10 4TG, UK.

 

Following the announcement of preliminary results for the financial year ended 30 September 2016 on 21 March, the Company announces that the Annual Report and Accounts and notice of Annual General Meeting have now been posted to shareholders. The Annual Report and Accounts is also available to view on Redx's website at www.redxpharma.com.

 

For further information, please contact:

 

Redx Pharma Plc

 

Neil Murray, Chief Executive Officer

T: +44 1625 469 900 

Karl Hård, Head of Investor Relations &

Corporate Communications

T: +44 7491 651 406

 

Cantor Fitzgerald Europe (Nomad & Broker)

 

T: +44 20 7894 7000

Phil Davies/ Michael Reynolds

 

 

 

WG Partners LLP (Joint Broker)

        T: +44 20 3705 9330

Claes Spång/ Chris Lee/ David Wilson

 

 

Consilium Strategic Communications

      T: +44 20 3709  5700                                        

Amber Fennell/ Matthew Neal/ Melissa Gardiner    

 

 

About Redx Pharma Plc

Company website: www.redxpharma.com 

Redx is focused on the discovery and development of proprietary, small molecule therapeutics to address areas of high, unmet medical need, principally in cancer, immunology and infection providing a pipeline of assets to larger and emerging companies. By improving the characteristics of existing drug classes to create highly differentiated, novel, best-in-class drugs, Redx has already established a broad portfolio of proprietary drug programs.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAKMGGDDNMGNZM



Redx Pharma Plc Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use